Quick Answer
Regenerative Medical Technology Group Inc. reported Shares Outstanding of 12.54 million shares for fiscal year 2024.
Regenerative Medical Technology Group Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 12.54M | +0.4% |
| 2023 | 12.49M | +0.4% |
| 2022 | 12.44M | +3.0% |
| 2021 | 12.09M | +11.2% |
| 2020 | 10.87M | +36.6% |
| 2019 | 7.96M | +62.4% |
| 2018 | 4.90M | +30.9% |
| 2017 | 3.74M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 12.54M | +0.0% | +0.0% |
| June 30, 2025 | 12.54M | +0.4% | +0.0% |
| March 31, 2025 | 12.54M | +0.4% | +0.0% |
| December 31, 2024 | 12.54M | +0.4% | +0.0% |
| September 30, 2024 | 12.54M | -10.7% | +0.4% |
| June 30, 2024 | 12.49M | +0.4% | +0.0% |
| March 31, 2024 | 12.49M | +0.4% | +0.0% |
| December 31, 2023 | 12.49M | +0.4% | -11.1% |
- Regenerative Medical Technology Group Inc. showed an increase of +0.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2017–2024 period, Regenerative Medical Technology Group Inc.’s shares outstanding has grown by 235.0% (from 3.74 million shares to 12.54 million shares).
- The most recent figure is from Regenerative Medical Technology Group Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: